(Q28244610)

English

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

scientific article (publication date: September 2011)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study (English)

0 references

0 references

0 references

0 references

1 reference

ChEBI release 2020-05-28

Yutaka Seino

1

0 references

Tetsuya Fujita

series ordinal

2

0 references

Shinzo Hiroi

series ordinal

3

0 references

Masashi Hirayama

series ordinal

4

0 references

Kohei Kaku

series ordinal

5

0 references

language of work or name

English

0 references

publication date

September 2011

0 references

published in

Current Medical Research and Opinion

0 references

volume

27

0 references

issue

9

0 references

page(s)

1781-92

0 references

Identifiers

DOI

10.1185/03007995.2011.599371

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2677399

OpenCitations bibliographic resource ID

2677399

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2677399

(Q28244610)

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)